HomeGPCR • NASDAQ
add
Structure Therapeutics Inc
Previous close
$68.94
Day range
$66.90 - $72.39
Year range
$13.24 - $94.90
Market cap
4.09B USD
Avg Volume
1.98M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 73.79M | 60.98% |
Net income | -65.71M | -93.40% |
Net profit margin | — | — |
Earnings per share | -0.37 | -85.00% |
EBITDA | -73.41M | -61.12% |
Effective tax rate | -0.16% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 799.04M | -12.70% |
Total assets | 832.16M | -10.83% |
Total liabilities | 62.14M | 70.64% |
Total equity | 770.02M | — |
Shares outstanding | 60.68M | — |
Price to book | 5.43 | — |
Return on assets | -22.38% | — |
Return on capital | -23.70% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -65.71M | -93.40% |
Cash from operations | -51.00M | -158.92% |
Cash from investing | -49.32M | 73.91% |
Cash from financing | 56.20M | 7,524.44% |
Net change in cash | -44.11M | 78.94% |
Free cash flow | -23.64M | -131.62% |
About
Founded
2016
Headquarters
Website
Employees
218
